Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$0.98−0.08 (-7.56%)

Close on Nov 13, 2026Market cap $638.94KP/E –Yield –

Decoy Therapeutics statistics

58 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $638.94K; $272.32M
Enterprise Value: -$7.53M; $146.23M
PB Ratio: 0.14; 2.00
P/TBV Ratio: 0.14; 2.22

Share statisticsIndustry

Shares Outstanding: 655,185; 58M
Shares Change (QoQ): 348.4%; 0.50%
Float: 580,375; 49M
Shares Held by Insiders: 11.4%; 11.7%
Shares Held by Institutions: 0.66%; 56.4%

Short sellingIndustry

Short Interest: 99,728; –
Short Interest Change: 2.18%; -0.80%
Short % of Float: 17.2%; 9.01%
Short % of Shares Outstanding: 15.2%; 6.30%
Days to Cover: 1.82; 5.15

Stock price statisticsIndustry

52-Week High: $16.92; –
52-Week Low: $0.90; –
20-Day Moving Average: $1.08; –
50-Day Moving Average: $1.78; –
200-Day Moving Average: $5.07; –
Average True Range (14): $0.15; –
Price Change (1 Week): -13.7%; -1.15%
Price Change (1 Month): -20.7%; -4.87%
Price Change (3 Months): -72.3%; -21.0%
Price Change (6 Months): -77.9%; -20.6%
Price Change (YTD): -87.5%; -23.6%
Price Change (1 Year): -92.9%; -22.4%
Price Change (3 Years): -99.9%; -29.5%
Price Change (5 Years): -100.0%; -77.9%
Price Change (10 Years): -100.0%; -65.4%
Average Volume (10 Days): 45,479; –
Average Volume (20 Days): 51,109; –
Average Volume (90 Days): 2M; –
Relative Volume: 0.07; 0.70
Relative Strength Index (14): 32.8; 43.4
Volatility (1 Year): 150.7%; 80.1%
Beta (5 Years): 0.77; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -11102.9%; -49.9%
Return on Assets (ROA): -222.5%; -40.6%
Return on Capital Employed (ROCE): -373.1%; -37.9%

Financial positionIndustry

Current Ratio: 1.97; 3.30
Quick Ratio: 1.92; 2.39

EfficiencyIndustry

Profits Per Employee: -$1.51M; -$689.41K
Employee Count: 11; 74
WACC: 8.97%; 10.2%

Income statement (TTM)Industry

Operating Income: -$16.96M; -$21.37M
Net Income: -$16.56M; -$22.35M
EBITDA: -$16.91M; -$17.21M

Balance sheetIndustry

Cash & Short-Term Investments: $8.17M; $68.68M
Net Cash (Debt): $8.17M; $17.76M
Net Cash Per Share: $12.47; $0.80
Equity (Book Value): $4.55M; $53.89M
Book Value Per Share: $6.94; $1.50
Tangible Book Value: $4.55M; $27.13M
Working Capital: $4.13M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$9.27M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -2592.4%; -21.8%

Scores and fair valueIndustry

Altman Z-Score: -21.96; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	DCOY	S&P 500	Difference	DCOY per year	S&P 500 per year
1 month	-21.4%	-3.0%	−18.3 pts
3 months	-72.4%	-2.8%	−69.6 pts
Year to date	-87.5%	+11.5%	−99.0 pts
1 year	-93.3%	+13.5%	−106.7 pts
3 years	-99.9%	+77.7%	−177.6 pts	-90.2%	+21.1%
5 years	-100.0%	+72.6%	−172.6 pts	-87.2%	+11.5%
10 years	-100.0%	+308.2%	−408.2 pts	-79.2%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M DCOY shares were sold short on Oct 30, 2026, up 2.2% from the previous report, or 17.18% of the shares available to trade. At recent volumes it would take 1.8 days to buy them back. Over the last 20 sessions, 33.1% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	99,728	+2.2%	54,726	1.8
Oct 15, 2026	97,605	-35.1%	119,437	1.0
Sep 30, 2026	150,336	+1321.2%	11,986,981	1.0
Sep 15, 2026	10,578	-19.6%	36,775	1.0
Aug 31, 2026	13,152	+23.2%	20,481	1.0
Aug 14, 2026	10,675	-57.7%	34,121	1.0
Jul 31, 2026	25,246	+5.3%	107,883	1.0
Jul 15, 2026	23,986	-84.7%	44,863	1.0
Jun 30, 2026	156,313	+7850.8%	1,217,647	1.0
Jun 15, 2026	1,966	-78.5%	18,536	1.0
May 29, 2026	9,158	+7.6%	14,898	1.0
May 15, 2026	8,514	-24.5%	8,258	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?